Page 181 - Vitamin D and Cancer
P. 181

168                                           E. Gocek and G.P. Studzinski

              82. Tuohimaa P, Lyakhovich A, Aksenov N, Pennanen P, Syvala H, Lou YR, Ahonen M, Hasan
               T, Pasanen P, Blauer M, Manninen T, Miettinen S, Vilja P, Ylikomi T (2001) Vitamin D and
               prostate cancer. J Steroid Biochem Mol Biol 76:125–134
              83. Moreno J, Krishnan AV, Swami S, Nonn L, Peehl DM, Feldman D (2005) Regulation of
               prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.
               Cancer Res 65:7917–7925
              84. Cussenot O, Villette JM, Cochand-Priollet B, Berthon P (1998) Evaluation and clinical value
               of neuroendocrine differentiation in human prostatic tumors. Prostate Suppl 8:43–51
              85. Xiao W, Hodge DR, Wang L, Yang X, Zhang X, Farrar WL (2004) Co-operative functions
               between nuclear factors NFkB and CCAT/enhancer-binding protein-beta (C/EBP-beta) regu-
               late the IL-6 promoter in autocrine human prostate cancer cells. Prostate 61:354–370
              86. Mori R, Xiong S, Wang Q, Tarabolous C, Shimada H, Panteris E, Danenberg KD, Danenberg
               PV, Pinski JK (2009) Gene profiling and pathway analysis of neuroendocrine transdifferenti-
               ated prostate cancer cells. Prostate 69:12–23
              87. Marcinkowska E, Garay E, Gocek E, Chrobak A, Wang X, Studzinski GP (2006) Regulation
               of C/EBPbeta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1, 25-di-
               hydroxyvitamin D3. Exp Cell Res 312:2054–2065
              88.  Abban G, Yildirim NB, Jetten AM (2008) Regulation of the vitamin D receptor and cornifin beta
               expression in vaginal epithelium of the rats through vitamin D3. Eur J Histochem 52:107–114
              89. White  JH  (2004)  Profiling  1,  25-dihydroxyvitamin  D3-regulated  gene  expression  by
                 microarray analysis. J Steroid Biochem Mol Biol 89–90:239–244
              90. Tomita K, van Bokhoven A, van Leenders GJ, Ruijter ET, Jansen CF, Bussemakers MJ,
               Schalken JA (2000) Cadherin switching in human prostate cancer progression. Cancer Res
               60:3650–3654
              91. Bikle DD, Ng D, Tu CL, Oda Y, Xie Z (2001) Calcium- and vitamin D-regulated keratino-
               cyte differentiation. Mol Cell Endocrinol 177:161–171
              92. Xie Z, Bikle DD (2007) The recruitment of phosphatidylinositol 3-kinase to the E-cadherin-
               catenin  complex  at the  plasma  membrane  is  required  for calcium-induced phospholipase
               C-gamma1 activation and human keratinocyte differentiation. J Biol Chem 282:8695–8703
              93. Falasca  M,  Logan  SK,  Lehto  VP,  Baccante  G,  Lemmon  MA,  Schlessinger  J  (1998)
               Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated mem-
               brane targeting. Embo J 17:414–422
              94. Xie Z, Singleton PA, Bourguignon LY, Bikle DD (2005) Calcium-induced human keratino-
               cyte differentiation requires src- and fyn-mediated phosphatidylinositol 3-kinase-dependent
               activation of phospholipase C-gamma1. Mol Biol Cell 16:3236–3246
              95. Bikle DD, Oda Y, Xie Z (2005) Vitamin D and skin cancer: a problem in gene regulation.
               J Steroid Biochem Mol Biol 97:83–91
              96.  Lehen’kyi V, Beck B, Polakowska R, Charveron M, Bordat P, Skryma R, Prevarskaya N (2007)
               TRPV6 is a Ca  entry channel essential for Ca -induced differentiation of human keratino-
                                               2+
                          2+
               cytes. J Biol Chem 282:22582–22591
              97. Johansen  C,  Iversen  L,  Ryborg  A,  Kragballe  K  (2000)  1alpha,  25-dihydroxyvitamin  D3
               induced  differentiation  of  cultured  human  keratinocytes  is  accompanied  by  a  PKC-
               independent regulation of AP-1 DNA binding activity. J Invest Dermatol 114:1174–1179
              98. Takahashi  H,  Ibe  M,  Honma  M,  Ishida-Yamamoto  A,  Hashimoto  Y,  Iizuka  H  (2003)  1,
               25-dihydroxyvitamin  D3  increases  human  cystatin  A  expression  by  inhibiting  the  Raf-1/
               MEK1/ERK signaling pathway of keratinocytes. Arch Dermatol Res 295:80–87
              99. Takahashi H, Honma M, Ishida-Yamamoto A, Namikawa K, Kiyama H, Iizuka H (2001)
               Expression of human cystatin A by keratinocytes is positively regulated via the Ras/MEKK1/
               MKK7/JNK signal transduction pathway but negatively regulated via the Ras/Raf-1/MEK1/
               ERK pathway. J Biol Chem 276:36632–36638
              100. Lippens S, Kockx M, Denecker G, Knaapen M, Verheyen A, Christiaen R, Tschachler E,
               Vandenabeele P, Declercq W (2004) Vitamin D3 induces caspase-14 expression in psoriatic
               lesions  and  enhances  caspase-14  processing  in  organotypic  skin  cultures.  Am  J  Pathol
               165:833–841
   176   177   178   179   180   181   182   183   184   185   186